Subtopic Deep Dive
Cardiac Ryanodine Receptor Dysfunction
Research Guide
What is Cardiac Ryanodine Receptor Dysfunction?
Cardiac Ryanodine Receptor Dysfunction refers to mutations and post-translational modifications in the RYR2 gene causing leaky calcium release channels that trigger catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic remodeling.
RYR2 mutations underlie CPVT, a stress-induced arrhythmia leading to bidirectional ventricular tachycardia and sudden death (Priori et al., 2001, 1364 citations). Clinical characterization shows incomplete penetrance and variable expressivity in mutation carriers (Priori et al., 2002, 1146 citations). Expert consensus links RYR2 defects to inherited arrhythmia syndromes requiring genetic testing (Priori et al., 2013, 1886 citations).
Why It Matters
RYR2 dysfunction drives sudden cardiac death in structurally normal hearts, as seen in CPVT families with hRyR2 mutations (Priori et al., 2001). Genetic testing identifies at-risk patients for beta-blocker therapy and ICD implantation (Ackerman et al., 2011; Priori et al., 2013). Therapeutic stabilization of leaky RyR2 channels offers targeted interventions for calcium-handling defects (Lanner et al., 2010). ARVD2-linked RYR2 mutations expand the phenotype to right ventricular remodeling (Tiso et al., 2001).
Key Research Challenges
Incomplete Penetrance in CPVT
RYR2 mutation carriers show variable arrhythmia onset, complicating risk stratification (Priori et al., 2002). Only 30-50% of carriers manifest symptoms by adolescence. Genotype-phenotype correlations remain elusive despite large cohorts.
Detecting Leaky RyR2 Channels
Post-translational modifications cause diastolic calcium leaks undetectable by standard imaging (Lanner et al., 2010). Functional assays in patient myocytes are invasive and low-throughput. Stabilizer drugs show variable efficacy across mutations.
Translating Mutations to Therapy
Over 150 RYR2 mutations link to CPVT and ARVD2, but few have mechanistic therapies (Priori et al., 2001; Tiso et al., 2001). Animal models poorly recapitulate human leakiness. Clinical trials lack endpoints for subclinical leaks.
Essential Papers
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Silvia G. Priori, Arthur A.M. Wilde, Minoru Horie et al. · 2013 · Heart Rhythm · 1.9K citations
Electrical, contractile and structural remodeling during atrial fibrillation
Maurits A. Allessie · 2002 · Cardiovascular Research · 1.4K citations
The natural history of atrial fibrillation (AF) is characterized by a gradual worsening with time. The recent finding that AF itself produces changes in atrial function and structure has provided a...
Mutations in the Cardiac Ryanodine Receptor Gene ( <i>hRyR2</i> ) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia
Silvia G. Priori, Carlo Napolitano, Natascia Tiso et al. · 2001 · Circulation · 1.4K citations
Background —Catecholaminergic polymorphic ventricular tachycardia is a genetic arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate int...
Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation
Tom O’Hara, László Virág, András Varró et al. · 2011 · PLoS Computational Biology · 1.2K citations
Cellular electrophysiology experiments, important for understanding cardiac arrhythmia mechanisms, are usually performed with channels expressed in non myocytes, or with non-human myocytes. Differe...
The Clinical Profile and Pathophysiology of Atrial Fibrillation
Jason G. Andrade, Paul Khairy, Dobromir Dobrev et al. · 2014 · Circulation Research · 1.2K citations
Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%–26%). The aim of this article is to review the clinical epidemiological features of AF and to relate them to und...
Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
Silvia G. Priori, Carlo Napolitano, Mirella Memmi et al. · 2002 · Circulation · 1.1K citations
Background — Mutations in the cardiac ryanodine receptor gene ( RyR2 ) underlie catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmogenic disease occurring in the st...
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Douglas P. Zipes, A. John Camm, Martin Borggrefe et al. · 2006 · Circulation · 1.1K citations
Reading Guide
Foundational Papers
Start with Priori et al. (2001) for RYR2-CPVT discovery and mutation mapping; Priori et al. (2002) for clinical profiles in 64 patients; Priori et al. (2013) for diagnostic guidelines.
Recent Advances
Ackerman et al. (2011) details genetic testing protocols; Lanner et al. (2010) reviews RyR2 structure-function for leak mechanisms.
Core Methods
Genetic screening via Sanger sequencing (Priori 2001); action potential modeling (O’Hara 2011); consensus genotyping algorithms (Ackerman 2011).
How PapersFlow Helps You Research Cardiac Ryanodine Receptor Dysfunction
Discover & Search
Research Agent uses citationGraph on Priori et al. (2001) to map 1364 citations linking RYR2 mutations to CPVT, then findSimilarPapers reveals Tiso et al. (2001) ARVD2 cluster. exaSearch queries 'RYR2 leak stabilizers CPVT' across 250M+ OpenAlex papers for therapeutic candidates.
Analyze & Verify
Analysis Agent runs readPaperContent on Priori et al. (2002) to extract penetrance data (30-50%), then verifyResponse with CoVe cross-checks against Ackerman et al. (2011) guidelines. runPythonAnalysis simulates calcium leak kinetics from O’Hara et al. (2011) model with NumPy, GRADE scores evidence as A-level for mutation causality.
Synthesize & Write
Synthesis Agent detects gaps in RyR2 stabilizer trials via contradiction flagging between Priori consensus papers, generates exportMermaid diagrams of RYR2 mutation networks. Writing Agent uses latexEditText to draft review sections, latexSyncCitations integrates 10 Priori papers, latexCompile produces arrhythmia pathway figures.
Use Cases
"Extract calcium leak parameters from RYR2 papers for Python simulation"
Research Agent → searchPapers('RYR2 diastolic leak') → Analysis Agent → readPaperContent(Lanner 2010) → runPythonAnalysis (NumPy curve fitting of leak rates) → matplotlib plot of simulated CPVT action potentials.
"Write LaTeX review on RYR2 mutations in CPVT with citations"
Synthesis Agent → gap detection (therapeutics post-Priori 2001) → Writing Agent → latexEditText('CPVT section') → latexSyncCitations(Priori 2001,2002,2013) → latexCompile → PDF with RYR2 pathway diagram.
"Find GitHub code for RyR2 ventricular models"
Research Agent → searchPapers('O’Hara Rudy model RyR2') → Code Discovery → paperExtractUrls(O’Hara 2011) → paperFindGithubRepo → githubRepoInspect → verified human ventricular AP simulator with RYR2 leak module.
Automated Workflows
Deep Research workflow scans 50+ RYR2 papers via searchPapers chains, producing structured report with GRADE-scored mutation penetrance tables from Priori cohorts. DeepScan's 7-step analysis verifies calcium leak mechanisms: readPaperContent(Lanner 2010) → runPythonAnalysis → CoVe checkpoints. Theorizer generates hypotheses on RyR2 stabilizers by synthesizing Priori clinical data with O’Hara computational models.
Frequently Asked Questions
What defines Cardiac Ryanodine Receptor Dysfunction?
RYR2 gene mutations or modifications cause sarcoplasmic reticulum calcium leaks, triggering CPVT with stress-induced bidirectional VT (Priori et al., 2001).
What are key methods to study RYR2 dysfunction?
Genetic sequencing identifies mutations; patch-clamp in HEK293 cells measures channel leakiness; computational models like O’Hara et al. (2011) simulate arrhythmogenic triggers.
What are seminal papers on this topic?
Priori et al. (2001, 1364 citations) discovered hRyR2 mutations in CPVT; Priori et al. (2002) characterized 60 families; Priori et al. (2013, 1886 citations) issued management consensus.
What open problems remain?
Incomplete penetrance mechanisms; non-invasive leak detection; mutation-specific stabilizers beyond beta-blockers.
Research Cardiac electrophysiology and arrhythmias with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiac Ryanodine Receptor Dysfunction with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers